Cargando…
Inhibiting IL-6 in COVID-19: we are not sure
Autores principales: | Honore, Patrick M., Barreto Gutierrez, Leonel, Kugener, Luc, Redant, Sebastien, Attou, Rachid, Gallerani, Andrea, De Bels, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384280/ https://www.ncbi.nlm.nih.gov/pubmed/32718345 http://dx.doi.org/10.1186/s13054-020-03177-x |
Ejemplares similares
-
Compared to NIPPV, HFNC is more dangerous regarding aerosol dispersion and contamination of healthcare personnel: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020) -
No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020) -
The causal link between hyperchloremia and acute kidney injury is yet to be conclusively established: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020) -
Acyclovir for ventilator-associated pneumonia refractory to antibiotics and with high viral herpes simplex load: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020) -
Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)